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Despite the availability of a variety of therapeutic
regimens for the treatment of patients with diabetes
mellitus, glycemic control is still fundamental in dia-
betes management. Better glycemic control decreases
the risk for the development of acute and chronic
diabetic complications, and optimizes quality of life
[1–3]. The patients’ behavioral changes and adher-
ence to a glycemic control program are associated with
their self-recognition of the disease state and their
knowledge of diabetes, which can be enhanced by the
implementation of a diabetes education plan [4–8]. In
fact, patient education delivered by certified diabetes
educators (CDEs) has become an important part of
the diabetes treatment program in medical settings
[9,10]. Nevertheless, the delivery of integrated care
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Tight control of blood sugar improves the outcomes for diabetic patients, but it can only be
achieved by adhering to a well-organized care plan. To evaluate the effect of a diabetes care plan
with reinforcement of glycemic control in diabetic patients, 98 ambulatory patients with type 2
diabetes who visited our diabetes clinic every 3–4 months and who completed four education
courses given by certified diabetes educators within 3 months after the first visit, were defined as
the Intervention group. A total of 82 patients fulfilling the inclusion criteria for the Intervention
group but who missed at least half of the diabetes education sessions were selected as controls.
Both groups had comparable mean hemoglobin A1c (HbA1c) levels at baseline, which decreased
significantly at 3 months and were maintained at approximately constant levels at intervals for
up to 1 year. The HbA1c decrement in the Intervention group was significantly greater than that
in the Control group over the 1-year follow-up period (HbA1c change: −2.5 ± 1.8% vs. −1.1 ± 1.7%,
p < 0.01). The maximal HbA1c decrement occurred during the first 3 months, and accounted for
95.6% and 94.6% of the total HbA1c decrements in the Intervention and Control groups, respec-
tively. In the multiple regression model, after adjustment for age, body mass index, and duration
of diabetes, the Intervention group may still have a 12.6% improvement in HbA1c from their
original value to the end of 1 year treatment compared with the Control group (p < 0.05). Diabetes
care, with reinforcement from certified diabetes educators, significantly improved and main-
tained the effects on glycemic control in ambulatory patients with type 2 diabetes.
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by diabetes specialists, nurses and dietitians, with rein-
forcement of drug adherence, self-glucose monitor-
ing and dietary control, also significantly contributes
to the management of diabetic patients and should not
be neglected [11–15].
To clarify whether an integrated care plan, includ-
ing diabetes education, does have benefits in terms of
the outcomes of glycemic control, however, remains
a challenge because of the coexistence of many other
factors, e.g. the demographic and physiological char-
acteristics of patients, teaching methods used, types
of antidiabetic medication, and the presence of com-
plications. Randomized control trials (RCTs) designed
by specialists from multiple disciplines and that incor-
porate the dedication of patients, healthcare providers
and institution facilities are highly recommended as
the most reliable study design to address this issue
[16]. However, meta-analysis of the results of several
RCTs revealed that patient education exerted only a
modest effect on the glycemic control of diabetic
patients [17–19]. Furthermore, the effect of an educa-
tion plan on glycemic control reportedly declined
over the diabetes disease course [18], unless self-
management was enhanced by reinforcement of the
education plan [20].
Thus, although diabetes education has an impor-
tant role in managing diabetic patients, the impor-
tance of diabetes education has been overemphasized.
However, the patient adherence to the care plan is
often overlooked. The purpose of the present study
was to determine whether adherence to a new dia-
betes care plan implemented at a regional hospital
was effective in enhancing the glycemic control of
ambulatory patients with type 2 diabetes.
MATERIALS AND METHODS
This study was conducted at a 464-bed regional hos-
pital of Kaohsiung City in southern Taiwan between
January 2000 and June 2001. Ambulatory patients
with diabetes were put under the care of a diabetes
team, which was composed of diabetes specialists,
nurses and dietitians of CDEs. We recruited 98 ambu-
latory patients with diabetes as the Intervention group
according to the following inclusion criteria: (1)
patients with type 2 diabetes who were diagnosed
and treated by diabetes specialists at the diabetes clinic
at our hospital; (2) patients with clear consciousness,
capable of verbal comprehension and communica-
tion, and independent in terms of self care; and (3)
patients able to return for regular follow-up at the
diabetes clinic every 3–4 months and take four dia-
betes education courses within 3 months after their
initial visit. To study the effectiveness of diabetes
education on glycemic control, another 82 diabetic
patients, who were regularly treated at out-patient
clinics, were selected retrospectively by chart review,
and fulfilled the inclusion criteria described above,
except that they had taken only one or two diabetes
education courses over 3 months, were included as
the Control group.
The introduction of diabetes mellitus and diabetes-
related complications, exercise, antidiabetic medica-
tion, dietary principles for control of blood glucose, and
social and psychological support, for example, were
all included in the education course. Two nurses, who
were qualified CDEs, were responsible for the imple-
mentation of this education program. The patients
referred to the CDEs from the diabetes specialists
were first evaluated by the CDEs, and then received a
30–45-minute one-to-one instruction from the CDEs
according to the disease status and needs of the
patient. The CDEs then arranged subsequent inter-
views in which education courses would be given
four times within 3 months after the first visit. In
addition, the patients were able to ask the CDEs
questions regarding their experiences and to obtain
answers in the subsequent follow-up periods until
the end of study. In terms of diabetes treatment, most
of the patients took oral hypoglycemic agents for
blood glucose control, and insulin was used by only
two patients. Basic demographic and physical char-
acteristics of the patients, presence of complications
and laboratory tests were investigated and collected
at baseline and every 3–4 months for 1 year. Blood
hemoglobin A1c (HbA1c) was measured with an
immunoassay, using a monoclonal antibody against
the conjugated site of glucose and six amino acids 
on the N-terminal of hemoglobin β chain. The extent
of the reaction was determined using an automatic
chemistry analyzer (COBAS INTEGRA 700; Roche
Diagnostics, Indianapolis, IN, USA).
Data processing, statistical analyses and graph
drawing were conducted using SPSS 11.0 (SPSS Inc.,
Chicago, IL, USA) and Prism 4.0 (GraphPad Software
Inc., San Diego, CA, USA). For the descriptive statistics
for demographic and other characteristics of patients
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in different groups, the continuous variables are
expressed as mean ± standard deviation, and categor-
ical variables are expressed as frequencies or percent-
ages. One-way repeated-measures analysis of variance
was used to determine the differences in HbA1c lev-
els within each group and between groups at various
time points. Values were compared between groups
using Student’s t test. Multiple regression analyses
were carried out to determine the effects of age, sex,
body mass index (BMI), duration of diabetes, group,
and duration of diabetes × group on the magnitude of
HbA1c improvement. The magnitude of HbA1c im-
provement was defined as the difference between the
HbA1c level at a particular time point and the base-
line level to the baseline level, and is expressed as a
percentage. A p value less than 0.05 was considered
to be statistically significant.
RESULTS
The patient characteristics and the levels of HbA1c
are shown in the Table. There were no significant 
differences between the Intervention and Control
groups in terms of age, sex ratio, marital status, edu-
cational level, family history of diabetes, body height,
body weight, BMI, smoking, and frequency of follow
up. Although the Control group had a longer dura-
tion of diabetes (8.8 ± 6.7 vs. 5.3 ± 5.7 years, p < 0.05),
the HbA1c levels at baseline were not significantly
Table. Characteristics of the Intervention and Control groups*†
Intervention group (n = 98) Control group (n = 82)
Age (yr) 57.5 ± 11.3 58.9 ± 11.0
Male 46.0 51.8
Married 98.0 100
Family history of diabetes 48.0 53.0
Body height (cm) 160.0 ± 7.7 159.6 ± 7.5
Body weight (kg) 65.0 ± 10.3 66.2 ± 11.4
Body mass index (kg/m2) 25.2 ± 3.3 25.8 ± 3.4
Education level
Below primary school 32.0 44.6
Primary and junior school 38.0 22.9
Above junior school 30.0 32.5
Smoking 24.0 21.7
Outpatient clinic visits
> 12 times 64.0 53.0
9–12 times 25.0 26.5
< 9 times 11.0 20.5
Duration of diabetes (yr)‡ 5.3 ± 5.7 8.8 ± 6.7
Diabetes-related complications
Neuropathy 35.0 38.6
Cardiovascular diseases‡ 6.0 15.7
Retinopathy 33.0 44.6
Nephropathy‡ 14.0 31.3
Laboratory data
Hemoglobin A1c at baseline (%) 9.4 ± 1.8 9.2 ± 1.5
*Data presented as mean ± standard deviation or %; †statistical comparisons using Student’s t test or χ2 test; ‡significant differences
between the Intervention and Control groups (p < 0.05).
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different between groups (Control group vs. Inter-
vention group: 9.2 ± 1.5% vs. 9.4 ± 1.8%, p > 0.05), and
there was no correlation between the duration of 
diabetes and the baseline HbA1c levels (r = −0.045,
p > 0.05; Pearson’s correlation). The percentage of
patients with complications, including cardiovascu-
lar diseases or nephropathy, was higher in the Control
group. However, the HbA1c levels in patients with or
without each complication were not different.
Despite the comparable HbA1c levels at baseline
in the two groups (Table), the HbA1c levels at 3 months,
6 months, 9 months and 12 months were lower in the
Intervention group than in the Control group (Figure
1). The repeated-measures analysis of variance re-
vealed that the differences in HbA1c levels at these
time points within each group and between both
groups were statistically significant. The HbA1c level
in the Intervention group was significantly lower
than that in the Control group at 12 months (HbA1c:
6.9 ± 1.2% vs. 7.9 ± 1.8%, p < 0.01; Figure 1A), and the
HbA1c decrement at 12 months in the Intervention
group was significantly greater than that in the Control
group (HbA1c: −2.5 ± 1.8% vs. −1.1 ± 1.7%, p < 0.01;
decrement: 26.7% vs. 12.5%; Figure 1B). The maximal
HbA1c decrement occurred during the first 3 months,
and accounted for 95.6% and 94.6% of the total
HbA1c decrements in the Intervention and Control
groups, respectively (Figure 1B).
Figure 2 shows the change in percentage in each
HbA1c category. In both groups, the percentages
shifted toward lower HbA1c categories at 3 months,
and the effect persisted for the duration of the study.
However, such a shift indicative of improved glycemic
control was more pronounced in the Intervention
group. To determine whether the decrement in HbA1c
was more pronounced during the first 3 months, the
differences in HbA1c between 3 months and baseline
were plotted against the baseline values in both groups
(Figure 3). This showed that higher absolute values
of HbA1c at baseline were associated with greater
HbA1c decrements at 3 months. This phenomenon
was more pronounced in the Intervention group than
in the Control group, as shown in Figure 3.
To identify the factors associated with the improve-
ment in HbA1c during the study period, a multiple
regression model with independent variables was
tested. The parameters associated with the magni-
tude of HbA1c improvement can be represented in a
regression equation:
Magnitude of HbA1c improvement = −28.435
+ (12.556 × Intervention group) + (0.954 × BMI)
+ (0.336 × age) − (0.504 × diabetes duration)
This equation revealed that the Intervention group
may have a 12.6% improvement in HbA1c from the
original value to that at 1 year compared with the
Control group (p < 0.05). However, the effect on the im-
provement of HbA1c was only 0.34% for age, 0.95%
for BMI, and decreased by 0.50% for diabetes dura-
tion (all p < 0.05). This model had an R2 of 0.198 and an
adjusted R2 of 0.179, which means that about 19.8%
of the variation in the improvement of HbA1c could
be explained by this model.
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Figure 1. (A) Hemoglobin A1c (HbA1c) levels (mean ± standard
error of the mean) in the Intervention group (n = 98) and Control
group (n = 82) at baseline and at time intervals of 3 months.
Significant differences are noted in the improvement of HbA1c
within each group (*p < 0.05) and between groups (†p < 0.05) by
repeated-measures analysis of variance. The differences between
the two groups are demonstrated to be significant at all time points,
except for at baseline, by Student’s t test (p < 0.01). (B) The mag-
nitude of HbA1c decrement at different intervals during the 
1-year study period in the Intervention group and Control group.
Statistically significant differences can be seen between groups at
3 months and for the total decrement (Student’s unpaired t test;
*p < 0.01). The HbA1c decrements are greatest at 3 months, and
were responsible for 95.6% and 94.6% of the total HbA1c decre-
ments in the Intervention and Control groups, respectively.
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Figure 2. The percentage of patients in each hemoglobin A1c (HbA1c) category at different time intervals during the 1-year study
period in the: (A) Intervention group (n = 98); and (B) Control group (n = 82). A greater proportion of patients shift towards the lower
HbA1c categories at 3 months compared with at baseline, and persist up to 1 year. This shift in HbA1c levels is more pronounced in the
Intervention group.
DISCUSSION
Although there is some discrepancy in the results,
several studies have revealed the beneficial effect of
integrated care and diabetes education on glycemic
control [4,5,21], based on whether a patient education
program becomes an integral part of diabetes man-
agement. In the present study, the HbA1c level of
patients who received a recently introduced diabetes
education plan decreased from 9.4 ± 1.8% at baseline
to 6.9 ± 1.2% at 12 months, corresponding to a decre-
ment of 26.7%, compared with a 12.5% decrement in
the Control group. The significant difference in HbA1c
change between the two groups demonstrates the ben-
eficial effect of the care plan. This finding was further
confirmed by the results of multiple regression analy-
sis, in which the group factor accounted for a 12.6%
reduction in the HbA1c level in the Intervention
group.
RCTs are considered the most reliable study design
to address the effect of diabetes education on glycemic
control [16]. Meanwhile, meta-analysis of the results
of several RCTs has been well addressed [17–19].
However, we were confined to a case-control study
because of the complexity in conducting an RCT in
this setting. This study was originally part of a pilot
study of a nation-wide program of diabetes educa-
tion and clinical pathways. It was not designed as an
RCT, and the main objective was to establish better
care of patients with diabetes through integrated care,
including the education plan. Nevertheless, this care
plan with its emphasis on diabetes education and
professional management led to positive outcomes in
terms of glycemic control.
In addition to the reports describing the varied
levels of success achieved by programs in promoting
glycemic control [17–19], Jiang et al [22] reported that
a diabetes education program improved the short-
term glycemic control in Taiwanese patients, and
determined that the intensity of diabetes education
Figure 3. Correlation between hemoglobin A1c (HbA1c) level at
baseline and HbA1c decrement at 3 months in the Intervention
(n = 81) and Control (n = 67) groups. This shows that absolute
values for HbA1c at baseline were associated with greater decre-
ments in HbA1c at 3 months. This phenomenon, as shown by
regression lines, was more pronounced in the Intervention group
(solid lines) than in the Control group (dash lines).
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was the only significant variable associated with the
decrease in fasting blood glucose. Keers et al [23]
showed that their Multidisciplinary Intensive Edu-
cation Programme improved glycemic control and
quality of life in diabetes patients with prolonged self-
management difficulties. Recently, Tien at al [24]
demonstrated the effectiveness of a comprehensive
diabetes care program in lowering the HbA1c levels.
They found that male patients with a shorter dura-
tion of diabetes history and higher baseline levels of
HbA1c were more likely to achieve better glycemic
control [24]. However, the magnitude of the HbA1c
decrement of up to 26.7% in the present study is
higher than that achieved in these three reports. In
Jiang et al’s study, the HbA1c decrement was 3.2%
and 7.4% in patients receiving basic and advanced
education programs, respectively, after 4 months of
care [22]. Meanwhile, in Keers et al’s study, the HbA1c
decrement was 5.1% at 3 months after the Multi-
disciplinary Intensive Education Programme [23].
Finally, in Tien et al’s study, the HbA1c decrement
was only 2.6% at 3 months [24]. Differences in patient
selection and patient characteristics might be respon-
sible for these differences.
In this study, we found that patients with higher
baseline HbA1c had larger HbA1c decrements, which
was also observed in another study [23]. Our patients
were not restricted to those with relatively high HbA1c
levels, as shown in Figure 3, and only 19.6% of patients
in the Intervention group and 14.6% in the Control
group had an HbA1c level less than 8.0%. This means
that our patients had relative high glycemic status,
which might explain why the magnitude in HbA1c
improvement was greater in our study. Furthermore,
a large proportion of our patients were newly diag-
nosed, newly referred and new receivers of diabetes
education (94%), meaning that they might display
better compliance compared with later stage diabetic
patients. Newly diagnosed patients with diabetes
have been shown to display better responses to med-
ication and the education plan from different aspects,
and thus generally have better glycemic control [25].
This might, at least partially, be because they have
more interest and motive for complying with med-
ication and dietary control in their daily living.
In addition, the majority of the HbA1c decrement
was achieved during the first 3 months of the inte-
grated care plan, which contributed 95.6% of the total
HbA1c decrement over the year. This means that the
effect of diabetes care on the improvement of glycemic
control was most pronounced during the initial phase
of the intervention program, during which the dia-
betes education was delivered. This result is consis-
tent with that in other studies [26,27]. Some studies
have demonstrated that a more intensive education
and care program might be required to achieve fur-
ther reduction in HbA1c levels [20]. Nevertheless,
maintaining the beneficial effect of diabetes educa-
tion on glycemic control is already a real challenge
[28]. A gradual deterioration in glycemic control has
been observed with prolongation of diabetes [8],
which can be attributed to factors such as increased
insulin resistance or decreased insulin secretion, lack
of response to antidiabetic medication, loss of patient
compliance, or fatigue on the part of the care facility.
Therefore, the absence of further improvements in
glycemic control in the subsequent 9 months might
not reflect the ineffectiveness of the integrated care
plan during that period of time but rather its remark-
able work in maintaining the effect on glycemic control
in consideration of persistent significant differences
in absolute HbA1c levels between the Intervention
and Control groups.
Limitations in the study design and interpretation
of the results should be carefully considered. Because
this was a retrospective study, selection bias in terms
of the study population could exist, although this was
minimized as much as possible. The Control group
had relatively longer duration of diabetes, and more
diabetic complications. These might hinder the im-
provements in glycemic control [29], although nei-
ther had an effect on the differences in HbA1c levels
between the groups in this study. Nevertheless, the
control patients were regularly followed-up. They
received treatment and their HbA1c was measured in
the same manner as the Intervention group; the only
difference was that the subjects in the Control group
participated in none, one or two diabetes education
sessions. The reasons for subject non-participation in
the courses were diverse. Some were followed-up at
night clinics, and others were unable to attend because
of personal or family reasons. By the very fact of
attending follow-up regularly, these subjects in the
Control group could be regarded as a group of patients
who have better compliance with medication and
dietary control compared with those who miss their
follow-up consultations. This might explain why
there was some improvement in their HbA1c levels
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during the study, albeit less than that in the Inter-
vention group [20].
The present study revealed that ambulatory
patients with type 2 diabetes who received an inte-
grated care plan, delivered by diabetes specialists
and CDEs, had better glycemic control over a 1-year
follow-up period. This effect was most pronounced
during the first 3 months; this period saw the major-
ity of the HbA1c decrement. Whether patients received
a diabetes care plan or not was the major determinant
for the improvement in glycemic control. Therefore, a
diabetes care plan implemented with a reinforcement
approach can provide better short-term improve-
ments and maintenance of glycemic control in ambu-
latory patients with type 2 diabetes.
ACKNOWLEDGMENTS
The authors would like to express their appreciation
to Yi-Hsin Yang, PhD, Associate Professor of the
Graduate Institute of Oral Health Science, College of
Oral Medicine, Kaohsiung Medical University, for
statistical advice.
REFERENCES
1. The Diabetes Control and Complications Trial Research
Group. The effect of intensive treatment of diabetes on
the development and progression of long-term compli-
cations in insulin-dependent diabetes mellitus. N Engl
J Med 1993;3299:977–86.
2. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin
therapy prevents the progression of diabetic microvascu-
lar complications in Japanese patients with non-insulin-
dependent diabetes mellitus: a randomized prospective
6-year study. Diabetes Res Clin Pract 1995;28:103–17.
3. UK Prospective Diabetes Study (UKPDS) Group. Effect
of intensive blood-glucose control with metformin 
on complications in overweight patients with type 2
diabetes (UKPDS 34). Lancet 1998;352:854–65.
4. Rubin RR, Peyrot M, Saudek CD. Effect of diabetes
education on self-care, metabolic control, and emotional
well-being. Diabetes Care 1989;12:673–9.
5. Raji A, Gomes H, Beard JO, et al. A randomized trial
comparing intensive and passive education in patients
with diabetes mellitus. Arch Intern Med 2002;162:
1301–4.
6. Panja S, Starr B, Colleran KM. Patient knowledge
improves glycemic control: is it time to go back to the
classroom? J Invest Med 2005;53:264–6.
7. Heisler M, Piette JD, Spencer M, et al. The relationship
between knowledge of recent HbA1c values and dia-
betes care understanding and self-management. Diabetes
Care 2005;28:816–22.
8. Goudswaard AN, Stolk RP, Zuithoff NP, et al. Long-
term effects of self-management education for patients
with Type 2 diabetes taking maximal oral hypogly-
caemic therapy: a randomized trial in primary care.
Diabetic Med 2004;1:17:491–6.
9. Mensing C, Boucher J, Cypress M, et al. National stan-
dards for diabetes self-management education. Diabetes
Care 2006;29(Suppl 1):S78–85.
10. American Diabetes Association. Third-party reimburse-
ment for diabetes care, self-management education, and
supplies. Diabetes Care 2006;29(Suppl 1):S68–9.
11. Day JL, Metcalfe J, Johnson P. Benefits provided by 
an integrated education and clinical diabetes centre: 
a follow-up study. Diabetic Med 1992;9:855–9.
12. Integrated care for diabetes: clinical, psychosocial, and
economic evaluation. Diabetes Integrated Care Eval-
uation Team. Br Med J 1994;308:1208–12.
13. Abourizk NN, O’Connor PJ, Crabtree BF, et al. An out-
patient model of integrated diabetes treatment and
education: functional, metabolic, and knowledge out-
comes. Diabetes Educ 1994;20:416–21.
14. van den Arend IJ, Stolk RP, Rutten GE, et al. Education
integrated into structured general practice care for
type 2 diabetic patients results in sustained improve-
ment of disease knowledge and self-care. Diabetic Med
2000;17:190–7.
15. Larsen DL, Cannon W, Towner S. Longitudinal assess-
ment of a diabetes care management system in an inte-
grated health network. J Manag Care Pharm 2003;9:
552–8.
16. Wheeler ML, Wylie-Rosett J, Pichert JW. Diabetes 
education research. Diabetes Care 2001;24:421–2.
17. Norris SL, Lau J, Smith SJ, et al. Self-management edu-
cation for adults with type 2 diabetes: a meta-analysis
of the effect on glycemic control. Diabetes Care 2002;25:
1159–71.
18. Norris SL, Engelgau MM, Narayan KM. Effectiveness
of self-management training in type 2 diabetes: a sys-
tematic review of randomized controlled trials. Diabetes
Care 2001;24:561–87.
19. Gary TL, Genkinger JM, Guallar E, et al. Meta-analysis
of randomized educational and behavioral interven-
tions in type 2 diabetes. Diabetes Educ 2003;29:488–501.
20. Rhee MK, Slocum W, Ziemer DC, et al. Patient adher-
ence improves glycemic control. Diabetes Educ 2005;31:
240–50.
21. Johnson JA, Eurich DT, Toth EL, et al. Generalizability
and persistence of a multifaceted intervention for im-
proving quality of care for rural patients with type 2
diabetes. Diabetes Care 2005;28:783–8.
22. Jiang YD, Chuang LM, Wu HP, et al. Assessment of the
function and effect of diabetes education programs in
Taiwan. Diabetes Res Clin Pract 1999;46:77–82.
Better glycemic control with diabetes team care
Kaohsiung J Med Sci April 2009 • Vol 25 • No 4 191
23. Keers JC, Bouma J, Links TP, et al. One-year follow-up
effects of diabetes rehabilitation for patients with pro-
longed self-management difficulties. Patient Educ Couns
2006;60:16–23.
24. Tien KJ, Hung HC, Hsaio JY, et al. Effectiveness of com-
prehensive diabetes care program in Taiwanese with
type diabetes. Diabetes Res Clin Pract 2008;79:276–83.
25. Tilly KF, Belton AB, McLachlan JF. Continuous moni-
toring of health status outcomes: experience with a
diabetes education program. Diabetes Educ 1995;21:
413–9.
26. Jenhani M, Gaha K, Nabouli R, et al. Effectiveness of
patient education on glycemic control in insulin treated
patients in general practice. Diabetes Metab 2005;31:
376–81.
27. Rothman RL, Malone R, Bryant B, et al. A randomized
trial of a primary care-based disease management pro-
gram to improve cardiovascular risk factors and gly-
cated hemoglobin levels in patients with diabetes. Am J
Med 2005;118:276–84.
28. Saaddine JB, Engelgau MM, Beckles GL, et al. A dia-
betes report card for the United States: quality of care
in the 1990s. Ann Intern Med 2002;136:565–74.
29. Schillinger D, Grumbach K, Piette J, et al. Association
of health literacy with diabetes outcomes. JAMA 2002;
288:475–82.
192 Kaohsiung J Med Sci April 2009 • Vol 25 • No 4
收文日期：97 年 11 月 14 日
接受刊載：98 年 4 月 13 日
通訊作者：黃尚志醫師
高雄醫學大學附設醫院內科
高雄市 807三民區自由一路 100號
第二型糖尿病病患遵從糖尿病照護計畫者
血糖控制較佳
邱怡文
1,6
  張哲銘
1,6
  林麗英
2
  張碧玉
4
  羅婉菁
2
  吳鈴珠
5
  陳惇杰
3
  黃尚志
3,6
高雄市立小港醫院 (委託高雄醫學大學經營 )  
1
內科  
2
護理部
高雄醫學大學附設醫院  
3
內科  
4
行政管理中心  
5
護理部
高雄醫學大學  醫學院  
6
腎臟照護學系
糖尿病患者嚴格的血糖控制可獲得較佳的預後，但必須有好的照護計畫。為評估糖尿
病照護與加強血糖控制計畫之成效，本研究收錄 98 名第二型糖尿病病患為介入組，
病患每三至四月門診一次，並於初次門診後的三個月內由經過認證之糖尿病衛教師教
育完成四次糖尿病衛教內容。另有 82 名相似條件的糖尿病患但未完成四次衛教者作
為控制組。兩組基礎期的糖化血色素質相近，而在第三個月時兩組各即呈有意義地下
降，而後一直平穩而持續地維持此一水準。一年多的追蹤期中，糖化血色素的降幅在
介入組明顯地大於控制組 (ΔHbA1c: –2.52 ± 1.84% vs. –1.14 ± 1.73%、p < 
0.01)。糖化血色素的最大降福發生於前三個月且各佔介入組與控制組整體降幅之 
95.6% 與 94.6%。控制年齡、性別、質量數、與糖尿病罹病期後之多重回歸模式顯
示，在經一年多的治療後糖化血色素的降幅在介入組較控制組大 12.6% (p < 0.05)。
我們結論由經過認證之糖尿病衛教師參與之糖尿病照護與加強血糖控制計畫可有意義
地改善與維持第二型糖尿病病患之血糖控制。
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